Skip to main content
. 2022 Mar 9;6:e2100181. doi: 10.1200/PO.21.00181

TABLE A2.

Additional Clinical Trials Using ctDNA-Based MRD Detection to Select Patients, Guide Treatment, or as Surrogate End Point

graphic file with name po-6-e2100181-g008.jpg